Peel Hunt Boosts ConvaTec Group PLC (CTEC) Price Target to GBX 380
ConvaTec Group PLC (LON:CTEC) had its price target lifted by Peel Hunt from GBX 300 ($3.87) to GBX 380 ($4.91) in a report released on Thursday. The brokerage currently has a “buy” rating on the stock. Peel Hunt’s price target would indicate a potential upside of 28.38% from the company’s current price.
A number of other equities analysts have also recently commented on the company. Royal Bank of Canada increased their target price on ConvaTec Group PLC from GBX 242 ($3.12) to GBX 278 ($3.59) and gave the company a “sector perform” rating in a report on Thursday, March 23rd. JPMorgan Chase & Co. reissued an “overweight” rating and set a GBX 305 ($3.94) target price on shares of ConvaTec Group PLC in a report on Thursday, March 30th. Goldman Sachs Group Inc reissued a “buy” rating and set a GBX 310 ($4.00) target price on shares of ConvaTec Group PLC in a report on Tuesday, March 21st. HSBC Holdings plc started coverage on ConvaTec Group PLC in a report on Thursday, January 19th. They set a “buy” rating and a GBX 310 ($4.00) target price for the company. Finally, Credit Suisse Group AG upped their price target on ConvaTec Group PLC from GBX 250 ($3.23) to GBX 275 ($3.55) and gave the company a “neutral” rating in a research report on Friday, March 3rd. Four analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of GBX 310.25 ($4.01).
ConvaTec Group PLC (LON:CTEC) traded up 0.34% during trading on Thursday, reaching GBX 296.00. The company’s stock had a trading volume of 7,783,435 shares. The firm’s market capitalization is GBX 5.70 billion. ConvaTec Group PLC has a one year low of GBX 213.00 and a one year high of GBX 312.90. The stock has a 50-day moving average of GBX 283.08 and a 200 day moving average of GBX 251.93.
ConvaTec Group PLC Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.